Omnicell (OMCL) Cash from Investing Activities Growth (1y) (2011 - 2026)
Powered by 
Analysis
Omnicell (OMCL) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -15.64% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -110.20% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -125.17% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -514.42% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -73.71% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -12.26% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -44.16% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 618.55% |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | -186.92% |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 21.30% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.30% |
| Mar 31, 2026 | -0.81% |
| Dec 31, 2025 | -6.28% |
| Sep 30, 2025 | -7.09% |
| Jun 30, 2025 | -17.52% |
| Mar 31, 2025 | -27.54% |
| Dec 31, 2024 | -9.67% |
| Sep 30, 2024 | 6.00% |
| Jun 30, 2024 | 8.56% |
| Mar 31, 2024 | 9.53% |
| Dec 31, 2023 | 28.29% |
| Sep 30, 2023 | 10.59% |
| Jun 30, 2023 | -117.35% |
| Mar 31, 2023 | 27.19% |
| Dec 31, 2022 | 91.03% |
| Sep 30, 2022 | 91.81% |
| Jun 30, 2022 | 48.94% |
| Mar 31, 2022 | -42.65% |
| Dec 31, 2021 | 18.72% |
| Sep 30, 2021 | -1,843.89% |